ARMCX4
gene geneOn this page
Also known as MGC40053GASP4
Summary
ARMCX4 (armadillo repeat containing X-linked 4, HGNC:28615) is a protein-coding gene on chromosome Xq22.1, encoding Armadillo repeat-containing X-linked protein 4 (Q5H9R4).
The product of this gene belongs to the armadillo repeat-containing family of proteins, which interact with other proteins in a variety of cellular processes. The function of this family member is currently unknown. Alternative splicing of this gene results in multiple transcript variants.
Source: NCBI Gene 100131755 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 17 total
- MANE Select transcript:
NM_001256155
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28615 |
| Approved symbol | ARMCX4 |
| Name | armadillo repeat containing X-linked 4 |
| Location | Xq22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC40053, GASP4 |
| Ensembl gene | ENSG00000196440 |
| Ensembl biotype | protein_coding |
| OMIM | 301046 |
| Entrez | 100131755 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 5 protein_coding_CDS_not_defined, 4 nonsense_mediated_decay, 1 protein_coding
ENST00000354842, ENST00000423738, ENST00000430461, ENST00000431677, ENST00000433011, ENST00000442270, ENST00000445416, ENST00000452188, ENST00000453574, ENST00000455331
RefSeq mRNA: 1 — MANE Select: NM_001256155
NM_001256155
CCDS: CCDS59170
Canonical transcript exons
ENST00000423738 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001678603 | 101485456 | 101485530 |
| ENSE00001772449 | 101488444 | 101495807 |
| ENSE00002215802 | 101486023 | 101486092 |
| ENSE00002218889 | 101487193 | 101487272 |
| ENSE00002284439 | 101487608 | 101487691 |
| ENSE00003583780 | 101488044 | 101488099 |
Expression profiles
Bgee: expression breadth ubiquitous, 239 present calls, max score 92.46.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.8120 / max 330.1331, expressed in 1427 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 196962 | 8.4095 | 1206 |
| 196961 | 1.7121 | 805 |
| 196960 | 0.5122 | 247 |
| 209759 | 0.1782 | 79 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left ovary | UBERON:0002119 | 92.46 | gold quality |
| type B pancreatic cell | CL:0000169 | 92.13 | gold quality |
| right ovary | UBERON:0002118 | 91.19 | gold quality |
| adenohypophysis | UBERON:0002196 | 91.08 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 90.35 | gold quality |
| pituitary gland | UBERON:0000007 | 90.18 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 89.92 | gold quality |
| thyroid gland | UBERON:0002046 | 89.47 | gold quality |
| olfactory bulb | UBERON:0002264 | 89.25 | gold quality |
| body of uterus | UBERON:0009853 | 89.14 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 89.01 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 88.92 | gold quality |
| ovary | UBERON:0000992 | 88.59 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 88.25 | gold quality |
| lower esophagus | UBERON:0013473 | 88.19 | gold quality |
| mucosa of stomach | UBERON:0001199 | 88.12 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 88.03 | gold quality |
| sural nerve | UBERON:0015488 | 87.93 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 87.81 | gold quality |
| right uterine tube | UBERON:0001302 | 87.50 | gold quality |
| tibial nerve | UBERON:0001323 | 87.50 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 87.39 | gold quality |
| left uterine tube | UBERON:0001303 | 87.38 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 87.13 | gold quality |
| calcaneal tendon | UBERON:0003701 | 87.12 | gold quality |
| left adrenal gland | UBERON:0001234 | 87.06 | gold quality |
| cerebellar cortex | UBERON:0002129 | 86.97 | gold quality |
| popliteal artery | UBERON:0002250 | 86.93 | gold quality |
| tibial artery | UBERON:0007610 | 86.90 | gold quality |
| right adrenal gland | UBERON:0001233 | 86.77 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.81 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
28 targeting ARMCX4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-5700 | 99.64 | 69.88 | 2280 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-4452 | 99.50 | 68.45 | 1493 |
| HSA-MIR-12132 | 99.47 | 68.90 | 1341 |
| HSA-MIR-372-5P | 99.41 | 69.11 | 2299 |
| HSA-MIR-888-5P | 99.30 | 70.15 | 1855 |
| HSA-MIR-10522-5P | 99.26 | 68.50 | 2087 |
| HSA-MIR-6071 | 99.16 | 67.77 | 1780 |
| HSA-MIR-8060 | 98.61 | 66.93 | 1187 |
| HSA-MIR-767-3P | 98.61 | 67.69 | 1192 |
| HSA-MIR-6502-3P | 97.86 | 65.43 | 569 |
| HSA-MIR-4724-3P | 97.57 | 67.31 | 785 |
| HSA-MIR-6847-3P | 96.50 | 67.30 | 582 |
| HSA-MIR-549A-5P | 96.35 | 68.08 | 587 |
| HSA-MIR-6828-3P | 96.06 | 67.61 | 1155 |
| HSA-MIR-6816-3P | 95.05 | 66.08 | 459 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | armc10 | ENSDARG00000062960 |
| mus_musculus | Armcx4 | ENSMUSG00000049804 |
| rattus_norvegicus | Armcx4 | ENSRNOG00000043128 |
| caenorhabditis_elegans | WBGENE00013456 |
Paralogs (10): ARMCX3 (ENSG00000102401), ARMCX5 (ENSG00000125962), ARMCX1 (ENSG00000126947), ARMC12 (ENSG00000157343), GPRASP2 (ENSG00000158301), ARMC10 (ENSG00000170632), ARMCX2 (ENSG00000184867), GPRASP3 (ENSG00000198908), GPRASP1 (ENSG00000198932), ARMCX6 (ENSG00000198960)
Protein
Protein identifiers
Armadillo repeat-containing X-linked protein 4 — Q5H9R4 (reviewed: Q5H9R4)
All UniProt accessions (2): A0A8J9A6E2, Q5H9R4
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the eutherian X-chromosome-specific Armcx family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5H9R4-1 | 1 | yes |
| Q5H9R4-2 | 2 | |
| Q5H9R4-3 | 3 |
RefSeq proteins (1): NP_001243084* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000225 | Armadillo | Repeat |
| IPR006911 | ARM-rpt_dom | Domain |
| IPR011989 | ARM-like | Homologous_superfamily |
| IPR016024 | ARM-type_fold | Homologous_superfamily |
Pfam: PF04826
UniProt features (33 total): compositionally biased region 11, region of interest 8, repeat 4, splice variant 4, sequence conflict 3, chain 1, transmembrane region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5H9R4-F1 | 40.98 | 0.02 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 117 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN, GGGTGGRR_PAX4_03, TGACATY_UNKNOWN, TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN, RYTTCCTG_ETS2_B, OCT1_B, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, TGGAAA_NFAT_Q4_01, GAVIN_FOXP3_TARGETS_CLUSTER_P3, GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP, YKACATTT_UNKNOWN, CDC5_01, LIU_PROSTATE_CANCER_DN, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN, WONG_ADULT_TISSUE_STEM_MODULE
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
982 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ARMCX4 | MFSD6L | Q8IWD5 | 560 |
| ARMCX4 | SH3RF2 | Q8TEC5 | 508 |
| ARMCX4 | ZNF605 | Q86T29 | 507 |
| ARMCX4 | CACHD1 | Q5VU97 | 503 |
| ARMCX4 | NECAB3 | Q96P71 | 498 |
| ARMCX4 | TRAPPC12 | Q8WVT3 | 493 |
| ARMCX4 | AP4S1 | Q9Y587 | 483 |
| ARMCX4 | ZSCAN29 | Q8IWY8 | 480 |
| ARMCX4 | UBAC2 | Q8NBM4 | 475 |
| ARMCX4 | CCDC163 | A0A0D9SF12 | 474 |
| ARMCX4 | RHPN1 | Q8TCX5 | 463 |
| ARMCX4 | TAX1BP3 | O14907 | 460 |
| ARMCX4 | RAB30 | Q15771 | 457 |
| ARMCX4 | S100A5 | P33763 | 456 |
| ARMCX4 | DPAGT1 | Q9H3H5 | 441 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ARMCX4 | PRKACB | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
| HUNK | ARMCX4 | psi-mi:“MI:0915”(physical association) | 0.000 |
ESM2 similar proteins: A0A0J9YWL9, A0A0J9YY54, A0A0U1RQI7, A0A494C071, A6NNC1, A6QL64, B3KS81, D3YZV8, E2RYF7, E9Q6E9, F1LWT0, F8W0I5, O60732, P0C8Z4, P0DKJ7, P0DKJ8, P0DKL2, P0DPF3, P18751, P20930, P43537, P53353, P59797, P62521, Q01456, Q08AG5, Q12816, Q3BBV2, Q5H9R4, Q5HY64, Q5JPF3, Q6P902, Q6ZQX7, Q86T75, Q86VE3, Q86VQ3, Q8BGJ3, Q8N307, Q8N7U7, Q8N7X1
Diamond homologs: B1WBW4, Q3UZB0, Q5H9R4, Q5JY77, Q5R4B2, Q5R7U0, Q5R9J3, Q5RDG2, Q5U310, Q5U4C1, Q5XID7, Q6A058, Q6P1M9, Q6PI77, Q7L311, Q8BHS6, Q8BUY8, Q8N2F6, Q920R4, Q96D09, Q9BE11, Q9CX83, Q9D0L7, Q9P291, Q9UH62, Q6PB60, Q71HP2, Q7L4S7, Q66HF0, Q8K3A6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
17 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
165 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:101488098:AGGT:A | donor_loss | 0.9900 |
| X:101488098:AGGTT:A | donor_gain | 0.9700 |
| X:101488100:G:GG | donor_gain | 0.9200 |
| X:101488097:CAGGT:C | donor_gain | 0.9000 |
| X:101488099:GGTT:G | donor_gain | 0.8600 |
| X:101489312:GACT:G | donor_gain | 0.8600 |
| X:101488096:ACAGG:A | donor_gain | 0.8500 |
| X:101488504:GCC:G | donor_gain | 0.8500 |
| X:101488100:G:A | donor_gain | 0.8400 |
| X:101489316:G:GG | donor_gain | 0.8400 |
| X:101488101:T:A | donor_gain | 0.8000 |
| X:101489307:G:GT | donor_gain | 0.7900 |
| X:101488095:TACAG:T | donor_gain | 0.7800 |
| X:101489461:A:AG | donor_gain | 0.7400 |
| X:101488074:G:GT | donor_gain | 0.7100 |
| X:101488070:A:T | donor_gain | 0.7000 |
| X:101488586:T:G | donor_gain | 0.6800 |
| X:101488605:G:GT | donor_gain | 0.6600 |
| X:101488438:TTCTA:T | acceptor_loss | 0.6400 |
| X:101488439:TCTAG:T | acceptor_loss | 0.6400 |
| X:101488440:CTAGG:C | acceptor_loss | 0.6400 |
| X:101488441:TA:T | acceptor_loss | 0.6400 |
| X:101488442:AGGT:A | acceptor_loss | 0.6400 |
| X:101488443:GGTCC:G | acceptor_loss | 0.6400 |
| X:101489325:GC:G | donor_gain | 0.6400 |
| X:101488436:A:AG | acceptor_loss | 0.6200 |
| X:101489315:T:TG | donor_gain | 0.6000 |
| X:101488585:A:AG | donor_gain | 0.5300 |
| X:101489326:C:G | donor_gain | 0.5000 |
| X:101492077:T:G | donor_gain | 0.4900 |
AlphaMissense
15029 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:101495149:T:C | L2187P | 0.998 |
| X:101495389:T:C | L2267P | 0.998 |
| X:101495023:T:C | L2145P | 0.997 |
| X:101495262:G:C | A2225P | 0.997 |
| X:101495266:T:C | L2226P | 0.997 |
| X:101495272:T:C | L2228P | 0.997 |
| X:101494774:C:A | A2062D | 0.996 |
| X:101494909:T:C | L2107P | 0.996 |
| X:101495041:T:C | L2151P | 0.996 |
| X:101495095:T:C | L2169P | 0.996 |
| X:101495191:T:C | L2201P | 0.996 |
| X:101494726:T:C | L2046P | 0.995 |
| X:101495215:T:C | L2209P | 0.995 |
| X:101495227:T:C | F2213S | 0.995 |
| X:101495263:C:A | A2225D | 0.995 |
| X:101495389:T:A | L2267H | 0.995 |
| X:101495071:T:A | V2161D | 0.994 |
| X:101495149:T:G | L2187R | 0.994 |
| X:101495188:T:C | L2200S | 0.994 |
| X:101494773:G:C | A2062P | 0.993 |
| X:101494896:G:C | A2103P | 0.993 |
| X:101495158:T:C | F2190S | 0.993 |
| X:101495196:G:C | A2203P | 0.993 |
| X:101495437:T:A | V2283D | 0.993 |
| X:101494905:G:C | A2106P | 0.992 |
| X:101495137:T:A | V2183D | 0.992 |
| X:101495149:T:A | L2187H | 0.992 |
| X:101495161:C:T | S2191F | 0.992 |
| X:101495331:T:C | F2248L | 0.992 |
| X:101495333:C:A | F2248L | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000015794 (X:101457275 A>C,G), RS1000066532 (X:101456635 A>T), RS1000176047 (X:101466594 A>G), RS1000264757 (X:101448090 C>A,T), RS1000293495 (X:101479960 T>A,C), RS1000364523 (X:101528278 C>G), RS1000434120 (X:101420290 C>T), RS1000445968 (X:101489629 T>C), RS1000473082 (X:101527165 A>G), RS1000528302 (X:101466916 A>G), RS1000777168 (X:101417800 C>A,T), RS1000816227 (X:101487057 G>C), RS1000887370 (X:101499348 G>A), RS1000911556 (X:101464604 C>T), RS1000991328 (X:101427381 C>T)
Disease associations
OMIM: gene MIM:301046 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression | 4 |
| Benzo(a)pyrene | affects methylation, decreases expression | 3 |
| Nickel | decreases expression | 2 |
| Smoke | decreases expression, increases expression | 2 |
| Cadmium Chloride | increases abundance, increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| nickel sulfate | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| entinostat | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Vorinostat | affects cotreatment, decreases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Endosulfan | increases expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| 8-Bromo Cyclic Adenosine Monophosphate | increases expression | 1 |
| Aflatoxin B1 | affects methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.